Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.02% Nasdaq Up0.11%

Boston Scientific Corporation (BSX)

-NYSE

8.19 Up 0.34(4.36%) 2:47PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Sep 29, 2012Jun 29, 2012Mar 30, 2012
Total Revenue 1,821,000   1,734,000   1,828,000   1,866,000  
Cost of Revenue582,000  558,000  578,000  631,000  
Gross Profit 1,239,000   1,176,000   1,250,000   1,235,000  
Operating Expenses
Research Development238,000  220,000  213,000  215,000  
Selling General and Administrative643,000  569,000  648,000  669,000  
Non Recurring144,000  894,000  3,877,000  58,000  
Others101,000  99,000  98,000  97,000  
Total Operating Expenses1,126,000  1,782,000  4,836,000  1,039,000  
Operating Income or Loss 117,000   (595,000) (3,586,000) 196,000  
Income from Continuing Operations
Total Other Income/Expenses Net3,000  7,000  31,000  (4,000)
Earnings Before Interest And Taxes116,000  (599,000)(3,555,000)192,000  
Interest Expense64,000  65,000  63,000  69,000  
Income Before Tax52,000  (664,000)(3,618,000)123,000  
Income Tax Expense(9,000) -  (40,000)10,000  
Minority Interest -   -   -   -  
Net Income From Continuing Ops61,000  (664,000)(3,578,000)113,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 61,000   (664,000) (3,578,000) 113,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 61,000   (664,000) (3,578,000) 113,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.